Socioeconomic Differences in Patient Survival Are Increasing for Acute Myeloid Leukemia and Multiple Myeloma in Sweden

被引:58
|
作者
Kristinsson, Sigurdur Yngvi [1 ]
Derolf, Asa Rangert
Edgren, Gustaf
Dickman, Paul W.
Bjoerkholm, Magnus
机构
[1] Karolinska Univ Hosp Solna, Dept Med, Div Hematol, SE-17176 Stockholm, Sweden
关键词
REMISSION INDUCTION; CANCER SURVIVAL; THERAPY; MORTALITY; DIAGNOSIS; STAGE; TRANSPLANTATION; MALIGNANCIES; ETHNICITY; DISTANCE;
D O I
10.1200/JCO.2008.18.2006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose An association between socioeconomic status (SES) and survival in acute myeloid leukemia (AML) and multiple myeloma (MM) has not been established in developed countries. We assessed the impact of SES on survival in two large population-based cohorts of AML and MM patients diagnosed in Sweden 1973 to 2005. Patients and Methods The relative risk of death (all cause and cause specific) in relation to SES was estimated using Cox's proportional hazards regression. We also conducted analyses stratified by calendar periods (1973 to 1979, 1980 to 1989, 1990 to 1999, and 2000 to 2005). Results We identified a total of 9,165 and 14,744 patients with AML and MM, respectively. Overall, higher white-collar workers had a lower mortality than other SES groups for both AML (P = .005) and MM (P < .005). In AML patients, a consistently higher overall mortality was observed in blue-collar workers compared with higher white-collar workers in the last three periods (hazard ratio [HR], 1.26; 95% CI, 1.05 to 1.51; HR, 1.23; 95% CI, 1.05 to 1.45; HR, 1.28; 95% CI, 1.04 to 1.57, respectively). In MM, no difference was observed in the first two calendar periods. However, in 1990 to 1999, self-employed (HR, 1.18; 95% CI, 1.02 to 1.37), blue-collar workers (HR, 1.18; 95% CI, 1.04 to 1.32), and retired (HR, 1.45; 95% CI, 1.16 to 1.80) had a higher mortality compared to higher white- collar workers. In 2000 to 2005, blue-collar workers had a higher mortality (HR, 1.31; 95% CI, 1.07 to 1.60) compared with higher white- collar workers. Conclusion SES was significantly associated with survival in both AML and MM. Most conspicuously, a lower mortality was observed among the highest SES group during more recent calendar periods. Differences in management, comorbidity, and lifestyle, are likely factors to explain these findings. J Clin Oncol 27: 2073-2080. (C) 2009 by American Society of Clinical Oncology
引用
收藏
页码:2073 / 2080
页数:8
相关论文
共 50 条
  • [31] Synchronous Development of Acute Myeloid Leukemia and Multiple Myeloma: A Rare Case Presentation
    Alrammahi, A.
    Ndam, F.
    Snower, D.
    Kapila, N.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2024, 162 : S88 - S88
  • [32] Association of an LMP2 Polymorphism with Acute Myeloid Leukemia and Multiple Myeloma
    Ozbas-Gerceker, Filiz
    Bozman, Nazli
    Kok, Selcuk
    Pehlivan, Mustafa
    Yilmaz, Mehmet
    Pehlivan, Sacide
    Oguzkan-Balci, Sibel
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (11) : 6399 - 6402
  • [33] Synchronous detection of multiple myeloma and acute myeloid leukemia: A diagnostic and therapeutic challenge
    Maral, Senem
    Albayrak, Murat
    Sahin, Osman
    Ozturk, Hacer Berna Afacan
    Han, Unsal
    Falay, Mesude
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (02) : 464 - 469
  • [34] Azacytidine for Concurrent Acute Monocytic Leukemia and Multiple Myeloma in an Elderly Patient
    Atas, Unal
    Tazegul, Gokhan
    Yucel, Orhan Kemal
    Ulas, Turgay
    Salim, Ozan
    Undar, Levent
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2020, 30 (02): : 110 - 112
  • [35] Sex differences in adults with acute myeloid leukemia and the impact of sex on overall survival
    Stabellini, Nickolas
    Tomlinson, Benjamin
    Cullen, Jennifer
    Shanahan, John
    Waite, Kristin
    Montero, Alberto J. J.
    Barnholtz-Sloan, Jill S. S.
    Hamerschlak, Nelson
    CANCER MEDICINE, 2023, 12 (06): : 6711 - 6721
  • [36] Smoking and the risk of leukemia, lymphoma, and multiple myeloma (Sweden)
    Adami, J
    Nyren, O
    Bergstrom, R
    Ekbom, A
    Engholm, G
    Englund, A
    Glimelius, B
    CANCER CAUSES & CONTROL, 1998, 9 (01) : 49 - 56
  • [37] Smoking and the risk of leukemia, lymphoma, and multiple myeloma (Sweden)
    Johanna Adami
    Olof Nyrén
    Reinhold Bergström
    Anders Ekbom
    Göran Engholm
    Anders Englund
    Bengt Glimelius
    Cancer Causes & Control, 1998, 9 : 49 - 56
  • [38] The increasing genomic complexity of acute myeloid leukemia
    Rowe, Jacob M.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2014, 27 (3-4) : 209 - 213
  • [39] Association between diabetes and acute lymphocytic leukemia, acute myeloid leukemia, non-Hopkin lymphoma, and multiple myeloma
    Ji Zhong Zhao
    Yu Cheng Lu
    Yan Min Wang
    Bo Lian Xiao
    Hong Yan Li
    Shao Chin Lee
    Li Juan Wang
    International Journal of Diabetes in Developing Countries, 2022, 42 : 694 - 702
  • [40] Development of multiple myeloma in a patient with chronic myeloid leukemia after treatment with imatinib mesylate
    Garipidou, V
    Vakalopoulou, S
    Tziomalos, K
    ONCOLOGIST, 2005, 10 (06): : 457 - 458